Amna Malik

14 papers receiving 319 citations

Peers

Amna Malik
Comparison fields: 5 of 69
  • Hepatology 56
  • Behavioral Neuroscience 13
  • Biological Psychiatry 8
  • Endocrinology, Diabetes and Metabolism 49
  • Epidemiology 94
Replace Yash Mittal with:
Yash Mittal United States
Luis‐Fernando Perez Spain
Shu Yan China
A. Aleotti Italy
Shimona Madalli United Kingdom
Anne Thouard France
Xiaofang Ji China
Ji Sun Moon South Korea
Sandra A. Rebuffat France
Oliver Schanz Germany
Amna Malik relative to Yash Mittal United States Yash Mittal's profile →
Citations per field
00.5×
Yash Mittal · 1×
Citations per year

Countries citing papers authored by Amna Malik

Since Specialization
Citations

This map shows the geographic impact of Amna Malik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amna Malik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amna Malik more than expected).

Fields of papers citing papers by Amna Malik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amna Malik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amna Malik. The network helps show where Amna Malik may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Amna Malik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amna Malik Line = papers co-authored together Amna Malik links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 20249
2 20242
3 20230
4 20222
5 20207
6 20192
7 201818
8 20181
9 20178
10 20157
11 201553
12 201417
13
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action.
199984
14 198932
15 198686

About Amna Malik

Amna Malik is a scholar working on Hepatology, Infectious Diseases, Virology, Genetics and Gastroenterology, having authored 15 papers that have together received 328 indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Platelet Disorders and Treatments (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Parvovirus B19 Infection Studies (2 papers), Immune Cell Function and Interaction (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Hepatology (56 citations), Behavioral Neuroscience (13 citations), Biological Psychiatry (8 citations), Endocrinology, Diabetes and Metabolism (49 citations) and Epidemiology (94 citations). Amna Malik has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include M G Low, Ravinder N. Maini, Marc Feldmann, L Marinova-Mutafchieva, D. Butler, Anne‐Marie Malfait, David D. Hackney, Kwame-Lante Wright, Philippa C. Matthews and Thumbi Ndung’u. Their work appears in journals such as PLoS ONE, Frontiers in Immunology, Blood, PLoS Pathogens and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026